Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 23, Pages 15969-15978
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-04-23
DOI
10.1074/jbc.m114.564252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines
- (2017) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication
- (2014) Moisés Pérez et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Investigation of the protein alkylation sites of the STAT3:STAT3 inhibitor Stattic by mass spectrometry
- (2013) Sibylle Heidelberger et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells
- (2013) P. Kroon et al. CANCER RESEARCH
- Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
- (2013) A. Quintas-Cardama et al. CLINICAL CANCER RESEARCH
- Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment
- (2013) Srikala S. Sridhar et al. EUROPEAN UROLOGY
- Inhibition of TGF-β signaling by the fungal lactones (S)-curvularin, dehydrocurvularin, oxacyclododecindione and galiellalactone
- (2012) Kristina Rudolph et al. CYTOKINE
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence That STAT3 Signaling Is Redox-Sensitive
- (2012) Carlos Zgheib et al. PLoS One
- Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development
- (2011) Ralf Buettner et al. ACS Chemical Biology
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
- (2011) Camilla Pilati et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
- (2011) Rebecka Hellsten et al. PLoS One
- Modulation of Gene Expression and Tumor Cell Growth by Redox Modification of STAT3
- (2010) L. Li et al. CANCER RESEARCH
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Stat3 Promotes Metastatic Progression of Prostate Cancer
- (2008) Junaid Abdulghani et al. AMERICAN JOURNAL OF PATHOLOGY
- Triterpenoid CDDO-Methyl Ester Inhibits the Janus-Activated Kinase-1 (JAK1)->Signal Transducer and Activator of Transcription-3 (STAT3) Pathway by Direct Inhibition of JAK1 and STAT3
- (2008) R. Ahmad et al. CANCER RESEARCH
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
- (2007) Rebecka Hellsten et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More